These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 29031070)
21. Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. Cao Z; Song Q; Yu G; Liu Z; Cong S; Tan Z; Deng Y Bioorg Med Chem; 2021 Apr; 35():116074. PubMed ID: 33640707 [TBL] [Abstract][Full Text] [Related]
22. Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties. Guzior N; Bajda M; Skrok M; Kurpiewska K; Lewiński K; Brus B; Pišlar A; Kos J; Gobec S; Malawska B Eur J Med Chem; 2015 Mar; 92():738-49. PubMed ID: 25621991 [TBL] [Abstract][Full Text] [Related]
23. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation. Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of flavone-8-acrylamide derivatives as potential multi-target-directed anti Alzheimer agents and investigation of binding mechanism with acetylcholinesterase. Shaik JB; Yeggoni DP; Kandrakonda YR; Penumala M; Zinka RB; Kotapati KV; Darla MM; Ampasala DR; Subramanyam R; Amooru DG Bioorg Chem; 2019 Jul; 88():102960. PubMed ID: 31102808 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease. Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958 [TBL] [Abstract][Full Text] [Related]
26. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease. Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075 [TBL] [Abstract][Full Text] [Related]
27. Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease. Jalili-Baleh L; Nadri H; Forootanfar H; Samzadeh-Kermani A; Küçükkılınç TT; Ayazgok B; Rahimifard M; Baeeri M; Doostmohammadi M; Firoozpour L; Bukhari SNA; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A Bioorg Chem; 2018 Sep; 79():223-234. PubMed ID: 29775948 [TBL] [Abstract][Full Text] [Related]
28. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease. Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794 [TBL] [Abstract][Full Text] [Related]
29. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease. Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Tan Z Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875 [TBL] [Abstract][Full Text] [Related]
31. New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease. Czarnecka K; Girek M; Maciejewska K; Skibiński R; Jończyk J; Bajda M; Kabziński J; Sołowiej P; Majsterek I; Szymański P J Enzyme Inhib Med Chem; 2017 Dec; 33(1):158-170. PubMed ID: 29210299 [TBL] [Abstract][Full Text] [Related]
32. Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease. Mi J; He Y; Yang J; Zhou Y; Zhu G; Wu A; Liu W; Sang Z Bioorg Med Chem Lett; 2022 Mar; 60():128574. PubMed ID: 35065231 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's disease. Zhao Y; Ye F; Xu J; Liao Q; Chen L; Zhang W; Sun H; Liu W; Feng F; Qu W Bioorg Med Chem; 2018 Jul; 26(13):3812-3824. PubMed ID: 29960728 [TBL] [Abstract][Full Text] [Related]
34. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study. Mollazadeh M; Mohammadi-Khanaposhtani M; Zonouzi A; Nadri H; Najafi Z; Larijani B; Mahdavi M Bioorg Chem; 2019 Jun; 87():506-515. PubMed ID: 30928873 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease. Wang K; Shi J; Zhou Y; He Y; Mi J; Yang J; Liu S; Tang X; Liu W; Tan Z; Sang Z Bioorg Chem; 2021 Jul; 112():104879. PubMed ID: 33915461 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease. Sang Z; Wang K; Zhang P; Shi J; Liu W; Tan Z Eur J Med Chem; 2019 Oct; 180():238-252. PubMed ID: 31310916 [TBL] [Abstract][Full Text] [Related]
37. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease. Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents. Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer's disease. Erdogan M; Kilic B; Sagkan RI; Aksakal F; Ercetin T; Gulcan HO; Dogruer DS Eur J Med Chem; 2021 Feb; 212():113124. PubMed ID: 33395623 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease. Choubey PK; Tripathi A; Tripathi MK; Seth A; Shrivastava SK Bioorg Chem; 2021 Jun; 111():104922. PubMed ID: 33945941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]